Press release from PR Newswire
PDL BioPharma Completes Regular Quarterly Dividend Payment
Thursday, September 12, 2013
PDL BioPharma Completes Regular Quarterly Dividend Payment07:00 EDT Thursday, September 12, 2013
INCLINE VILLAGE, Nev., Sept. 12, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the September 12, 2013, regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of September 5, 2013, the record date.
About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new income generating assets and maximizing value for its shareholders. For more information, please visit www.pdl.com.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.
SOURCE PDL BioPharma, Inc.
For further information: Peter S. Garcia, PDL BioPharma, Inc., 775-832-8500, email@example.com; Jennifer Williams, Cook Williams Communications, Inc., 360-668-3701, firstname.lastname@example.org